Matthew L. Sherman, EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 971 shares at $15.10 ($15K) on 2023-02-16, disclosed to the SEC on 2023-02-17.
Seasonal sale ($15k) by EVP & Chief Medical Officer — this insider has traded DCPH in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |